ConductScience.org, home

Paper36901812

Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.

Gajewska-Naryniecka A and 5 others. Int J Mol Sci, 2023. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method. Papers, record 36901812. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901812

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2024-09-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gajewska-Naryniecka AAgnieszkahttps://orcid.org/0000-0002-0181-3850
2Szwedowicz UUrszula
3Łapińska ZZofiahttps://orcid.org/0000-0001-5070-2746
4Rudno-Rudzińska JJulia
5Kielan WWojciech
6Kulbacka JJulitahttps://orcid.org/0000-0001-8272-5440

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Humans
Combined Modality Therapy
Electroporation
Treatment Outcome

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IREC project No. 2020/ABM/01/00098/P/02Medical Research AgencyPubMed

Source PubMed

Download CSV of grants

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118415132The effect of electroporation pulses on functioning of the heart.Med Biol Eng Comput2008https://conductscience.org/library/papers/18415132PubMed
224975085Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro.Biomed Pharmacother2014https://conductscience.org/library/papers/24975085PubMed
326328033Irreversible electroporation and the pancreas: What we know and where we are going?World J Gastrointest Surg2015https://conductscience.org/library/papers/26328033PubMed
433374223Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer.Pharmaceutics2020https://conductscience.org/library/papers/33374223PubMed
526258317Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.Ann Surg2015https://conductscience.org/library/papers/26258317PubMed
629986632Electrochemotherapy as a New Modality in Interventional Oncology: A Review.Technol Cancer Res Treat2018https://conductscience.org/library/papers/29986632PubMed
734303953New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study.Surg Oncol2021https://conductscience.org/library/papers/34303953PubMed
826874618Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells.Bioelectrochemistry2016https://conductscience.org/library/papers/26874618PubMed
927393627Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma.J Surg Oncol2016https://conductscience.org/library/papers/27393627PubMed
1028106146Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies.Sci Rep2017https://conductscience.org/library/papers/28106146PubMed
1124238374Tumor ablation: common modalities and general practices.Tech Vasc Interv Radiol2013https://conductscience.org/library/papers/24238374PubMed
1235139717Irreversible electroporation in renal tumours: A systematic review of safety and early oncological outcomes.Urologia2022https://conductscience.org/library/papers/35139717PubMed
1326906114Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.Eur J Surg Oncol2016https://conductscience.org/library/papers/26906114PubMed
1433638687Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.Eur Radiol2021https://conductscience.org/library/papers/33638687PubMed
1522475953A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected.Bioelectrochemistry2012https://conductscience.org/library/papers/22475953PubMed
1626633834Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model.PLoS One2015https://conductscience.org/library/papers/26633834PubMed
1723177107Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.J Vasc Interv Radiol2012https://conductscience.org/library/papers/23177107PubMed
1829191513International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.Pancreatology2018https://conductscience.org/library/papers/29191513PubMed
1925170201Therapeutic options for the management of pancreatic cancer.World J Gastroenterol2014https://conductscience.org/library/papers/25170201PubMed
2026622097Irreversible Electroporation.Semin Intervent Radiol2015https://conductscience.org/library/papers/26622097PubMed

See all 84 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42975837Feasibility of real-time 1.5-T MR-guided percutaneous irreversible electroporation in a porcine model.Eur Radiol Exp2026https://conductscience.org/library/papers/42975837PubMed
42719117The electrical tumor microenvironment: abnormalities and opportunities.Front Oncol2026https://conductscience.org/library/papers/42719117PubMed
42688057Does tumor location affect irreversible electroporation outcomes in pancreatic cancer? A head-to-head comparative cohort study.Front Oncol2026https://conductscience.org/library/papers/42688057PubMed
41991586Combination of irreversible and calcium electroporation to overcome heterogeneity-associated incomplete ablation in the pancreas.Sci Rep2026https://conductscience.org/library/papers/41991586PubMed
41976359Systematic Review and Meta-Analysis of Current and Novel Approaches in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/41976359PubMed
41890743Experimental study on synergistic pulses improving the tumor microenvironment and assisting immunotherapy.Front Immunol2026https://conductscience.org/library/papers/41890743PubMed
41047430Pancreatic cancer in the era of precision medicine: challenges, advances, and the future of therapeutic strategies.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/41047430PubMed
41046199Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model.Ultrasound Med Biol2026https://conductscience.org/library/papers/41046199PubMed
40923270High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine.Int J Surg2026https://conductscience.org/library/papers/40923270PubMed
40647392Endoscopic Immuno-Oncology: A New Frontier in Treatment of Pancreatic Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40647392PubMed
40108103A Soft Spot for Bleeding: Pseudoaneurysm of the Gastroduodenal Artery in a 71-Year-Old Woman Undergoing Electroporation for a Pancreatic Head Cancer.Dig Dis Sci2025https://conductscience.org/library/papers/40108103PubMed
40076917Investigation of the Bystander Effect on Cell Viability After Application of Combined Electroporation-Based Methods.Int J Mol Sci2025https://conductscience.org/library/papers/40076917PubMed
39898755Foundational insights for theranostic applications of magnetoelectric nanoparticles.Nanoscale Horiz2025https://conductscience.org/library/papers/39898755PubMed
39766257Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses.Biomolecules2024https://conductscience.org/library/papers/39766257PubMed
39712216Modulating the Cell Death Immune Response for Electroporation Treatments.Bioelectricity2024https://conductscience.org/library/papers/39712216PubMed
39658672Radiofrequency ablation (RFA) in unresectable pancreatic adenocarcinoma: meta-analysis & systematic review.Surg Endosc2025https://conductscience.org/library/papers/39658672PubMed
39589586Advances in irreversible electroporation for prostate cancer.Discov Oncol2024https://conductscience.org/library/papers/39589586PubMed
39354834Evaluation of cryoablation using a prototype cryoablation needle in swine liver.Clin Endosc2024https://conductscience.org/library/papers/39354834PubMed
38673901The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.Int J Mol Sci2024https://conductscience.org/library/papers/38673901PubMed
38644713Smart Nanobiomaterials for Gene Delivery in Localized Cancer Therapy: An Overview from Emerging Materials and Devices to Clinical Applications.Curr Cancer Drug Targets2025https://conductscience.org/library/papers/38644713PubMed

See all 22 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36901812

GET https://conductscience.org/api/papers/v1/36901812/references?page=2